Context, Purpose and Broader Policy Frame

The European Central Bank has sent a targeted information request to a subset of banks to determine whether those lenders are supplying credit to investors that buy significant risk transfers (SRTs), and if so how that credit is structured, collateralised and priced. Pedro Machado set out the exercise publicly as a diagnostic intended to map funding links and potential circular exposures that could turn purportedly off‑loaded risk back into bank losses under stress. The inquiry covers bilateral credit lines, repo-style financing, committed facilities and margining practices — effectively seeking transaction-level detail rather than relying on headline SRT volumes alone.

The ECB’s fact‑finding aligns with recent work by Basel Committee advisers and the Financial Stability Board, which have warned that investor-funded SRT structures can mask economic risk concentrations and that current prudential metrics may overstate resilience. Those bodies have flagged persistent data gaps — inconsistent reporting formats, scarce transaction‑level disclosure and limited visibility on ultimate loss absorbers — and recommended harmonised templates, joint supervisory protocols and cross‑border stress testing that capture investor-funded chains.

Operationally, supervisors aim to identify whether banks are extending credit to SRT buyers in ways that create circularity — for example when dealer balance sheets are reduced on a legal basis but economic risk or funding links remain concentrated across interconnected counterparties. Evidence of pervasive bank-funded investor participation would raise questions about the adequacy of capital and liquidity buffers, margining practices in secured funding lines, and the need for clearer definitions of genuine risk transfer versus retained economic exposure.

For market participants the inquiry is likely to have near-term behavioural effects. Banks may tighten counterparty limits, reduce repo or committed facility exposure to SRT investors, reprice funding and demand more collateral, or pre-emptively change internal risk-weighting assumptions. Over time, supervisors could move from diagnostics to policy actions: mandated granular reporting, adjusted risk weights, targeted disclosure requirements, coordinated cross-border examinations or stress tests that incorporate both balance-sheet and market-side dynamics.

Constraints on the ECB’s ability to draw policy conclusions are real. Heterogeneous reporting systems, bilateral contract complexity and lack of common identifiers mean the survey will produce uneven data quality unless paired with agreed templates and reconciliation protocols — the very reforms the Basel Committee recommends. That helps explain why international bodies are emphasising legal and operational upgrades as well as data harmonisation before calibrating capital or margin frameworks.

The probe should also be seen in a wider strategic context: euro-area authorities are simultaneously taking other steps to shore up funding backstops and market functioning, including an announced expansion of euro liquidity access for certain counterparties. That parallel policy activity reflects a two-track approach — diagnostic data collection to inform rulemaking, alongside operational measures designed to mitigate immediate funding squeezes.

The short‑to‑medium term trade-off is predictable: increased transparency and the prospect of tighter prudential treatment should reduce tail‑risk, but may also contract liquidity in SRT and dealer-intermediation markets and raise funding costs for market‑making desks. The ultimate regulatory response will hinge on the survey’s granularity and the degree to which supervisors can trace ultimate loss‑absorbing capacity across jurisdictions.